Inhalation & nasal development and manufacturing services

Recipharm offers a range of inhalation manufacturing and development capabilities for novel respiratory products.

Our facilities include:

  • Commercial manufacturing capabilities for pMDI and nasal spray
  • DPI manufacturing suite, ready for customer’s bespoke equipment
  • Pilot plant, including small scale pMDI manufacture (directly scaleable to commercial manufacturing)
  • Seven clinical and development suites with dedicated team of scientists and engineers
  • State-of-the-art quality control laboratories
  • Extensive suite of ICH stability cabinets In house microbiology laboratory

Recipharm Inhalation Solutions™ offers an integrated service for inhalation drug products and devices spanning early stage development to commercial manufacture.

Learn more about our capabilities by downloading our fact sheet below.